Intrapartum and postpartum antibiotic use in seven low- and middle-income countries: Findings from the A-PLUS trial

BJOG. 2025 Jan;132(1):72-80. doi: 10.1111/1471-0528.17930. Epub 2024 Aug 14.

Abstract

Objective: To describe the intrapartum and postpartum use of non-study antibiotics in low- and middle-income countries (LMICs) during the double-blinded NICHD Global Network Azithromycin in Labor (A-PLUS) trial.

Design: The antibiotic use sub-study was a planned prospective, observational sub-study of the A-PLUS trial.

Settings: The study was carried out in hospitals or health centres affiliated with eight sites of the Global Network for Women's and Children's Health Research (Global Network) in seven countries: Bangladesh, Pakistan, India (two sites), Kenya, Zambia, The Democratic Republic of the Congo (DRC) and Guatemala.

Population: Totally, 29 278 pregnant women enrolled in the A-PLUS trial.

Methods: We collected data on 29 278 pregnant women admitted to a facility for delivery related to non-study antibiotic use overall and during three time periods: (1) in the facility prior to delivery, (2) after delivery until facility discharge and (3) after discharge to 42 days post-partum.

Main outcome measures: Non-study antibiotic use overall and for treatment or prophylaxis by the site during the three time periods.

Results: Of the 29 278 women in the study, 5020 (17.1%; 95% CI 16.7%-17.6%) received non-study antibiotics in the facility prior to delivery, 11 956 (40.8%; 95% CI 40.3%-41.4%) received non-study antibiotics in the facility after delivery, and 13 390 (47.6%; 95% CI 47.0%-48.2%) women received non-study antibiotics after delivery and after facility discharge. Antibiotics were prescribed more often among women in the Asian and Guatemalan sites than in the African sites. In the three time-periods, among those receiving antibiotics, prophylaxis was the indication in 82.3%, 97.7% and 90.7% of the cases, respectively. The type of antibiotics used varied substantially by time-period and site, but generally, penicillin-type drugs, cephalosporin-type drugs and metronidazole were used more frequently than other types.

Conclusions: Across the eight sites of the Global Network, in the facility before delivery, and in the post-partum periods before and after facility discharge, antibiotics were used frequently, but use was highly variable by site and time-period.

Keywords: A‐PLUS trial; infection; low‐ and middle‐income countries; maternal antibiotics; pregnancy.

Publication types

  • Multicenter Study
  • Observational Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / therapeutic use
  • Antibiotic Prophylaxis / statistics & numerical data
  • Azithromycin* / therapeutic use
  • Bangladesh
  • Democratic Republic of the Congo
  • Developing Countries*
  • Double-Blind Method
  • Female
  • Guatemala
  • Humans
  • India
  • Kenya
  • Pakistan
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Prospective Studies
  • Puerperal Infection / drug therapy
  • Puerperal Infection / prevention & control
  • Zambia

Substances

  • Anti-Bacterial Agents
  • Azithromycin